Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
Puig, N, Sarasquete, M E, Balanzategui, A, Martínez, J, Paiva, B, García, H, Fumero, S, Jiménez, C, Alcoceba, M, Chillón, M C, Sebastián, E, Marín, L, Montalbán, M A, Mateos, M V, Oriol, A, Palomera, L, de la Rubia, J, Vidriales, M B, Bladé, J, Lahuerta, J J, González, M, Miguel, J F S, García-Sanz, R
Published in Leukemia (01.02.2014)
Published in Leukemia (01.02.2014)
Get full text
Journal Article
Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
Rosiñol, L, Oriol, A, Teruel, A I, de la Guía, A L, Blanchard, MaJ, de la Rubia, J, Granell, M, Sampol, MaA, Palomera, L, González, Y, Etxebeste, MaA, Martínez-Martínez, R, Hernández, M T, de Arriba, F, Alegre, A, Cibeira, MaT, Mateos, MaV, Martínez-López, J, Lahuerta, J J, San Miguel, J, Bladé, J
Published in Leukemia (01.09.2017)
Published in Leukemia (01.09.2017)
Get full text
Journal Article
Targeting vasculogenesis to prevent progression in multiple myeloma
Moschetta, M, Mishima, Y, Kawano, Y, Manier, S, Paiva, B, Palomera, L, Aljawai, Y, Calcinotto, A, Unitt, C, Sahin, I, Sacco, A, Glavey, S, Shi, J, Reagan, M R, Prosper, F, Bellone, M, Chesi, M, Bergsagel, L P, Vacca, A, Roccaro, A M, Ghobrial, I M
Published in Leukemia (01.05.2016)
Published in Leukemia (01.05.2016)
Get full text
Journal Article
Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis
Ramírez-Labrada, A., López-Royuela, N., Jarauta, V., Galán-Malo, P., Azaceta, G., Palomera, L., Pardo, J., Anel, A., Marzo, I., Naval, J.
Published in Clinical & translational oncology (01.02.2015)
Published in Clinical & translational oncology (01.02.2015)
Get full text
Journal Article
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation : t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
GUTIERREZ, N. C, CASTELLANOS, M. V, PALOMERA, L, GARDELLA, S, ESCODA, L, HERNANDEZ-BOLUDA, J. C, BELLO, J. L, DE LA RUBIA, J, LAHUERTA, J. J, SAN MIGUEL, J. F, MARTIN, M. L, MATEOS, M. V, HERNANDEZ, J. M, FERNANDEZ, M, CARRERA, D, ROSINOL, L, RIBERA, J. M, OJANGUREN, J. M
Published in Leukemia (2007)
Published in Leukemia (2007)
Get full text
Journal Article
The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed refractory multiple myeloma
GARCIA-SANZ, R, GONZALEZ-PORRAS, J. R, VARGAS-PABON, M, GUTIERREZ, O. N, RODRIGUEZ, J. A, SAN MIGUEL, J. F, HERNANDEZ, J. M, POLO-ZARZUELA, M, SUREDA, A, BARRENETXEA, C, PALOMERA, L, LOPEZ, R, GRANDE-GARCIA, C, ALEGRE, A
Published in Leukemia (01.04.2004)
Published in Leukemia (01.04.2004)
Get full text
Journal Article
Matched-pairs analysis of outcomes with bortezomib, melphalan, and prednisone (VMP) treatment for previously untreated multiple myeloma (MM) using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials
Mateos, M.-V, Oriol, A, Martínez-López, J, Teruel, A.-I, Bengoechea, E, Palomera, L, de Arriba, F, Esseltine, D.-L, Cakana, A, Pei, L, van de Velde, H, San Miguel, J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
LONG‐TERM RESULTS OF THE MULTICENTER PHASE II TRIAL WITH BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT FOR PATIENTS WITH MALT LYMPHOMA (MALT‐2008‐01)
Salar, A., Domingo‐Domenech, E., Panizo, C., Nicolás, C., Bargay, J., Muntañola, A., Canales, M., Bello, J., Sancho, J., Tomás, J., Rodriguez, M., Peñalver, F.J., Palomera, L., Grande, C., Sánchez‐Blanco, J.J., Arranz, R., Conde, E., Garcia, M., García, J.F., Caballero, D., Montalbán, C.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
BENDAMUSTINE AS PART OF CONDITIONING REGIMEN FOR AUTOLOGOUS STEM‐CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE LYMPHOMAS: FINAL ANALYSIS OF A PHASE 2 STUDY FROM GELTAMO
Martín, A., Redondo, A.M., Valcárcel, D., González, A.P., Suárez‐Lledó, M., Bello, J.L., Canales, M., Gayoso, J., Conde, E., Jarque, I., Campo, R., Arranz, R., Terol, M.J., Rifón, J., Rodríguez, M.J., Ramírez, M.J., Castro, N., Sánchez, A., López‐Jiménez, J., Briones, J., López, A., Palomera, L., Caballero, D.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
AUTOLOGOUS STEM CELL TRANSPLANTATION MAY POTENTIALLY ABROGATE THE NEGATIVE PROGNOSTIC EFFECT OF EARLY RELAPSE AFTER CHEMO OR INMUNOCHEMOTHERAPY IN FOLLICULAR LYMPHOMA
Jiménez Ubieto, A., Grande, C., Caballero, D., Yañez, L., Novelli, S., Hernández‐Garcia, M., Manzanares, M., Arranz, R., Ferreiro, J., Bobillo, S., Mercadal, S., Galego, A., López‐Jiménez, J., Moraleda, J., Vallejo, C., Albo, C., Pérez‐Ceballos, E., Marrero, C., Magnano, L., Palomera, L., Jarque, I., Martín, A., Coria, E., López‐Guillermo, A., Salar, A., Lahuerta, J.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BRCAP AS FIRST LINE TREATMENT IN YOUNG PATIENTS WITH HIGH‐RISK DLBCL. A STUDY FROM SPANISH GROUP GELTAMO
Gonzalez‐Barca, E., Carrillo, E., Grande, C., Martín, A., Montes‐Moreno, S., Coronado, M., Mercadal, S., Roncero, J.M., Perez De Oteyza, J., Nicolas, C., Rodriguez‐Salazar, M.J., Sancho, J.M., Palomera, L., Lopez, J., Albo, C., Peñalver, F.J., Hernandez, J.A., Lopez‐Guillermo, A., Ramirez, M.J., Jarque, I., Bargay, J., Canales, M., Conde, E., Caballero, D.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control
Paiva, B, Granell, M, De Arriba, F, Montalban, M.-A, Alegre, A, Diaz-Mediavilla, J, Lahuerta, J.-J, San Miguel, J.F, Palomera, L, de la Rubia, J, Corchete, L, Echeveste, M.-A, Cordon, L, Terol, M.-J, De Paz, R, Gutierrez, N.C, Martinez-Lopez, J, Gorosquieta, A, Blade, J, Orfao, A, Vidriales, M.-B, Rosinol, L, Mateos, M.-V, Ocio, E.M, Oriol, A
Published in Leukemia (01.10.2013)
Published in Leukemia (01.10.2013)
Get full text
Journal Article
Treatment of renal failure in patients with newly diagnosed multiple mieloma with bortezomib and dexamethasone: results of a phase II trial from PETHEMA/GEM group (RENVEL)
Rosiñol, L, Oriol, A, Blanchard, M.J, Palomera, L, Mateos, M.V, de la Rubia, J, Hernández, M.T, Díaz-Mediavilla, J, Hernández, M, Jiménez, R, Motlló, C, Lahuerta, J.J, San Miguel, J, Bladé, J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Outcome of Patients with Extramedullary Plasmacytomas (EMPs) Included in a Phase III PETHEMA/GEM Study of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)
Jiménez, R, Rosiñol, L, Teruel, A.I, dela Rubia, J, Mateos, M.V, Hernández, M.T, Hernández, D, Blanchard, M.J, Iñigo, B, Palomera, L, Krsnik, I, Tomás, J.F, Gutiérrez, N.C, San Miguel, J, Lahuerta, J.J, Bladé, J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Pretransplant induction with VTD (Bortezomib/Thalidomide/Dexamethasone) significantly improves PFS: long-term results of the randomized phase 3 PETHEMA/GEM study
Rosiñol, L, Oriol, A, Teruel, A.I, Hernández, D, Blanchard, M.J, de la Rubia, J, Granell, M, Besalduch, J, Palomera, L, González, Y, Etxebeste, M.A, Díaz-Mediavilla, J, Hernández, M.T, de Arriba, F, Gutiérrez, N.C, Martín-Ramos, M.L, Cibeira, M.T, Mateos, M.V, Martínez-López, J, Alegre, A, Lahuerta, J.J, San Miguel, J, Bladé, J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
372 Serum LDH and ferritin: Improvement of risk assessment in lower risk MDS
Azaceta, G, Dourdil, V, Olave, T, Malo, M, Valle, S, Palomera, L
Published in Leukemia research (2011)
Published in Leukemia research (2011)
Get full text
Journal Article
Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34 bone marrow cell compartments from patients with myelodysplastic syndromes
Suárez, L, Vidriales, M B, Sanz, G, López, A, López-Berges, M C, de Santiago, M, Palomera, L, Bernal, T, Pérez de Equiza, M E, San Miguel, J F, Orfao, A
Published in Leukemia (01.07.2004)
Published in Leukemia (01.07.2004)
Get full text
Journal Article
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
Sanoja-Flores, L., Flores-Montero, J., Garcés, J. J., Paiva, B., Puig, N., García-Mateo, A., García-Sánchez, O., Corral-Mateos, A., Burgos, L., Blanco, E., Hernández-Martín, J., Pontes, R., Díez-Campelo, M., Millacoy, P., Rodríguez-Otero, P., Prosper, F., Merino, J., Vidriales, M. B., García-Sanz, R., Romero, A., Palomera, L., Ríos-Tamayo, R., Pérez-Andrés, M., Blanco, J. F., González, M., van Dongen, J. J. M., Durie, B., Mateos, M. V., San-Miguel, J., Orfao, A.
Published in Blood cancer journal (New York) (19.11.2018)
Published in Blood cancer journal (New York) (19.11.2018)
Get full text
Journal Article
Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma
Palomera, L, Azaceta, G, Varo, MJ, Soria, J, Gutierrez, M
Published in Haematologica (Roma) (01.11.1998)
Get full text
Published in Haematologica (Roma) (01.11.1998)
Journal Article